Damya Laoui

9.2k citations

60 papers · 5.5k · 3 hit papers · h-index 31

Impact in

Immunology top 0.5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Phagocytosis and Immune Regulation
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis

Papers in

Immunology 51
- Immune cells in cancer 37
- Immune Cell Function and Interaction 23
- Immunotherapy and Immune Responses 17
- Phagocytosis and Immune Regulation 11
Molecular Biology 20
- Epigenetics and DNA Methylation 7

Co-authors: Jo A. Van Ginderachter (40 shared papers)Patrick De Baetselier (15 shared papers)Kiavash Movahedi (14 shared papers)Eva Van Overmeire (14 shared papers)Jan Van den Bossche (6 shared papers)Jiri Keirsse (11 shared papers)Conny Gysemans (4 shared papers)Geert Raes (9 shared papers)
Journals: Frontiers in Immunology (8 papers)Cancers (5 papers)Cancer Research (5 papers)Immunobiology (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
Partner nations: Belgium Germany Netherlands

In The Last Decade

Damya Laoui

58 papers receiving 5.5k citations

Damya Laoui's Hit Papers

align trajectories log scale

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade 2017 · 444 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Science Translational Medicine
2013 Cancer Cell
2010 Cancer Research

Peers

Countries citing papers authored by Damya Laoui

Since Specialization

Citations

This map shows the geographic impact of Damya Laoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damya Laoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damya Laoui more than expected).

Fields of papers citing papers by Damya Laoui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damya Laoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damya Laoui. The network helps show where Damya Laoui may publish in the future.

Co-authors

The 25 scholars most cited alongside Damya Laoui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Damya Laoui Line = papers co-authored together Damya Laoui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes Cancer Research ·Kiavash Movahedi, Damya Laoui, Conny Gysemans, Martijn Baeten, Geert Stangé, Jan Van den Bossche, Matthias Mack, Daniël Pipeleers, Pieter In 'T Veld, Patrick De Baetselier, Jo A. Van Ginderachter Hit paper breakdown →	2010	964
2	Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity Cancer Cell ·Andrea Casazza, Damya Laoui, Mathias Wenes, Sabrina Rizzolio, Nicklas Bassani, Marco Mambretti, Sofie Deschoemaeker, Jo A. Van Ginderachter, Luca Tamagnone, Massimiliano Mazzone Hit paper breakdown →	2013	477
3	Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade Science Translational Medicine ·Martina Schmittnaegel, Nicolò Rigamonti, Ece Kadioglu, Antonino Cassará, Céline Wyser Rmili, Anna Kiialainen, Yvonne Kienast, H.P. Mueller, Chia-Huey Ooi, Damya Laoui, Michele De Palma Hit paper breakdown →	2017	444
4	Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population Cancer Research ·Damya Laoui, Eva Van Overmeire, Giusy Di Conza, Chiara Aldeni, Jiri Keirsse, Yannick Morias, Kiavash Movahedi, Isabelle Houbracken, Elio Schouppe, Yvon Elkrim, Oussama Karroum, Bénédicte F. Jordan, Peter Carmeliet, Conny Gysemans, Patrick De Baetselier, Massimiliano Mazzone, Jo A. Van Ginderachter	2013	338
5	Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions The International Journal of Developmental Biology ·Damya Laoui, Kiavash Movahedi, Eva Van Overmeire, Jan Van den Bossche, Elio Schouppe, Camille Mommer, Alexandros Nikolaou, Yannick Morias, Patrick De Baetselier, Jo A. Van Ginderachter	2011	250
6	Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages Cancer Research ·Kiavash Movahedi, Steve Schoonooghe, Damya Laoui, Isabelle Houbracken, Wim Waelput, Karine Breckpot, Luc Bouwens, Tony Lahoutte, Patrick De Baetselier, Geert Raes, Nick Devoogdt, Jo A. Van Ginderachter	2012	244
7	Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression Immunity ·Manesh Chittezhath, Manprit Kaur Dhillon, Jyue Yuan Lim, Damya Laoui, Irina N. Shalova, Yi Ling Teo, Jinmiao Chen, Revathy Kamaraj, Lata Raman, Josephine Lum, Thomas Paulraj Thamboo, Edmund Chiong, Francesca Zolezzi, Henry Yang, Jo A. Van Ginderachter, Michael Poidinger, Alvin Wong, Subhra K. Biswas	2014	217
8	The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity Nature Communications ·Damya Laoui, Jiri Keirsse, Yannick Morias, Eva Van Overmeire, Xenia Geeraerts, Yvon Elkrim, Máté Kiss, Evangelia Bolli, Qods Lahmar, Dorine Sichien, Jens Serneels, Charlotte L. Scott, Louis Boon, Patrick De Baetselier, Massimiliano Mazzone, Martin Guilliams, Jo A. Van Ginderachter	2016	215
9	Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity Nature Cell Biology ·Caroline Baer, Mario Leonardo Squadrito, Damya Laoui, Danielle Thompson, Sarah K. Hansen, Anna Kiialainen, Sabine Hoves, Carola H. Ries, Chia-Huey Ooi, Michele De Palma	2016	210
10	M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment Cancer Research ·Eva Van Overmeire, Benoı̂t Stijlemans, Felix Heymann, Jiri Keirsse, Yannick Morias, Yvon Elkrim, Lea Brys, Chloé Abels, Qods Lahmar, Can Ergen, Lars Vereecke, Frank Tacke, Patrick De Baetselier, Jo A. Van Ginderachter, Damya Laoui	2015	191
11	Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression Frontiers in Immunology ·Damya Laoui, Eva Van Overmeire, Patrick De Baetselier, Jo A. Van Ginderachter, Geert Raes	2014	163
12	Mechanisms Driving Macrophage Diversity and Specialization in Distinct Tumor Microenvironments and Parallelisms with Other Tissues Frontiers in Immunology ·Eva Van Overmeire, Damya Laoui, Jiri Keirsse, Jo A. Van Ginderachter, Adélaïda Sarukhan	2014	147
13	PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using ¹⁸F-Radiolabeled Camelid Single-Domain Antibody Fragments Journal of Nuclear Medicine ·Anneleen Blykers, Steve Schoonooghe, Catarina Xavier, Kevin D’hoe, Damya Laoui, Matthias D’Huyvetter, Ilse Vaneycken, Frederik Cleeren, Guy Bormans, Johannes Heemskerk, Geert Raes, Patrick De Baetselier, Tony Lahoutte, Nick Devoogdt, Jo A. Van Ginderachter, Vicky Caveliers	2015	134
14	Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Qods Lahmar, Jiri Keirsse, Damya Laoui, Kiavash Movahedi, Eva Van Overmeire, Jo A. Van Ginderachter	2015	123
15	Myeloid cell heterogeneity in cancer: not a single cell alike Cellular Immunology ·Máté Kiss, Sofie Van Gassen, Kiavash Movahedi, Yvan Saeys, Damya Laoui	2018	120
16	Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer Cancers ·Patrik Kovács, Tamás Csonka, Tündé Kovàcs, Zsanett Sári, Gyula Ujlaki, Adrien Sipos, Zsolt Karányi, Dóra Szeőcs, Csaba Hegedűs, Karen Uray, L Jankó, Máté Kiss, Borbála Kiss, Damya Laoui, László Virág, Gábor Méhes, Péter Bai, Edit Mikó	2019	90
17	Systemic Reprogramming of Monocytes in Cancer Frontiers in Oncology ·Máté Kiss, Aarushi Audhut, Geert Raes, Damya Laoui	2020	87
18	Mononuclear phagocyte heterogeneity in cancer: Different subsets and activation states reaching out at the tumor site Immunobiology ·Damya Laoui, Eva Van Overmeire, Kiavash Movahedi, Jan Van den Bossche, Elio Schouppe, Camille Mommer, Alexandros Nikolaou, Yannick Morias, Patrick De Baetselier, Jo A. Van Ginderachter	2011	82
19	Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages Molecular Imaging and Biology ·Catarina Xavier, Anneleen Blykers, Damya Laoui, Evangelia Bolli, Ilse Vaneyken, Jessica Bridoux, Henri Baudhuin, Geert Raes, Hendrik Everaert, Kiavash Movahedi, Jo A. Van Ginderachter, Nick Devoogdt, Vicky Caveliers, Tony Lahoutte, Marleen Keyaerts	2019	79
20	Tumor‐induced myeloid‐derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8⁺T‐cell activation events European Journal of Immunology ·Elio Schouppe, Camille Mommer, Kiavash Movahedi, Damya Laoui, Yannick Morias, Conny Gysemans, Ariane Luyckx, Patrick De Baetselier, Jo A. Van Ginderachter	2013	78

About Damya Laoui

Damya Laoui is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Neurology, having authored 60 papers that have together received 5.5k indexed citations. Recurring topics across this work include Immune cells in cancer (37 papers), Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (12 papers), Phagocytosis and Immune Regulation (11 papers), Epigenetics and DNA Methylation (7 papers), Chemokine receptors and signaling (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Immunology (3.6k citations), Oncology (2.3k citations), Cancer Research (858 citations), Molecular Biology (1.9k citations) and Neurology (232 citations). Damya Laoui has collaborated with scholars based in Belgium, Germany and Netherlands. Frequent co-authors include Jo A. Van Ginderachter, Patrick De Baetselier, Kiavash Movahedi, Eva Van Overmeire, Jan Van den Bossche, Jiri Keirsse, Conny Gysemans, Geert Raes, Yannick Morias and Geert Stangé. Their work appears in journals such as Frontiers in Immunology, Cancers, Cancer Research, Immunobiology and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Damya Laoui

Impact in

Papers in i

In The Last Decade

Damya Laoui

Damya Laoui's Hit Papers

Peers

Countries citing papers authored by Damya Laoui

Fields of papers citing papers by Damya Laoui

All Works

About Damya Laoui

Explore authors with similar magnitude of impact

Papers in